Home
  • Our Company
    • Biopharmaceutical Acceleration Model®
    • Dynamic Assembly®
    • Kinetic™
    • Syneos One®
    • The Trusted Process®
    • Our Leadership
    • Our Vision, Mission and Values
    • Resource Library
    • Events
    • Awards
    • Site Relationships
    • Our Office Locations
  • Solutions
    • Clinical Development
      • Full Service
        • Bioanalytical Solutions
        • Early Phase
        • Phase II - III
        • Phase IIIb - IV
        • Real World and Late Phase
        • Medical Device and Diagnostics
      • FSP 360
        • Biostatistics and Statistical Programming
        • Clinical Data Management
        • Clinical Development Services Project Management
        • Clinical Monitoring
        • Drug Safety and Pharmacovigilance
        • Investigator Management Solutions
        • Medical Writing and Communications
        • Rater Training
        • Site Start Up
        • Site and Patient Access
        • Trial Master File Operations
    • Commercialization
      • Advertising
      • Behavioral Insights
      • Brand Commercialization
      • Brand Naming and Development
      • Clinical Field Teams
      • Commercial Model of the Future
      • Commercial Recruiting Solutions
      • Communications
      • Deployment Solutions
      • Digital and Social Media
      • Health Economics and Outcomes Research
      • Integrated Commercial Solutions
      • Medical Affairs Transformation
      • Medical Communications
      • Medication Engagement
      • Policy and Advocacy
      • Portfolio Strategy
      • Public Relations
      • REMS and Risk Management (PMO)
      • Reputation and Risk Management
      • Selling Solutions
      • Syndicated Market Research and Insights
      • Training and Learning Solutions
      • Value and Access
    • Consulting
      • Commercial Advisory Group
        • Portfolio Strategy and Transactions
        • Health Economics and Outcomes Research
        • Product and Franchise Strategy
        • Value and Access
        • Customer and Digital Engagement
      • Scientific and Medical Affairs Advisory Group
        • Medical Affairs
        • Quality and Compliance
        • Regulatory
      • Risk and Program Management Advisory Group
        • REMS and Risk Management (PMO)
      • R&D Advisory Group
        • Research and Development
    • Syneos One®
  • Therapeutic Expertise
    • Therapeutic Areas
      • Cardiovascular
      • Central Nervous System
        • CNS Analgesia
        • CNS Clinical Surveillance Team
        • CNS Neurology
        • CNS Psychiatry
      • Endocrine and Metabolic
      • Gastroenterology
      • Immunology and Inflammation
      • Infectious Disease
      • Oncology and Hematology
        • Targeted Therapies
        • Novel and Emerging Therapies
        • Immuno-Oncology
      • Ophthalmology
      • Respiratory
      • Women's Health
    • Cross-Functional Solutions
      • Biosimilars
      • Cell and Gene Therapy
      • Pediatrics
      • Rare Diseases
    • Our Experience Hub
  • Insights Hub
  • Careers
  • 中途採用
  • 新卒採用 (日本)
  • News
    • In The News
    • Press Releases
    • Press Kit
  • Investors
  • Investigators
  • Transparency
  • Suppliers
    • Supplier Code of Conduct
    • Supplier Diversity and Inclusion
    • Supplier Terms and Conditions
  • Contact
  • English
  • Français Canadien
  • 日本語

Search form

Home Insights Hub The 2021 Health Trends Series Post-Surge Capacity
Trends

Post-Surge Capacity

December 31, 2020
Content 

 

Subscribe to our Newsletter

Post-Surge Capacity

2021 Health Trends
Columns 
Content 
Image or Video 

Post-Surge Capacity.jpg

Post-Surge Capacity
Content 

Are you tired yet? A lot of your colleagues may be. Professionals and business leaders burst into the pandemic world with incredible amounts of energy and innovation. But as the weeks became months and quarters and … well, that surge capacity and seemingly endless adaptivity has definitely been depleted. 

 

Leaders are looking at this crisis through a new lens: moving from strategies to deal with an acutely stressful situation to managing through indefinite uncertainty. This approach looks at an unfolding, cascading set of challenges that impact every person, every team, every family differently, and tries to create programs and language that keep them all connected and moving forward together.

Critical Question

How do we best support and optimize teams living and working in ways that have profoundly disrupted their lives, families, focus and sense of security?

Sparks for Post-Surge Capacity
Columns 
Content 
Image or Video 

Ambiguous Loss.png

Ambiguous Loss

Ambiguous Loss: “It’s harder for high achievers. The more accustomed you are to solving problems, to getting things done, to having a routine, the harder it will be on you because none of that is possible right now. You get feelings of hopelessness and helplessness, and those aren’t good.”

— Pauline Boss, PhD, University of Minnesota

Content 
Image or Video 

Q3 2021.png

Q3 2021

Q3 2021: Many trusted analysts are pointing to next fall as the next possibility for near-normal the way we remember it. Even then, offices may convert to “dynamic workplaces” that continue to encourage teams to work virtually, but have space and opportunity to bring them together on select days of the week or against big projects and collaboration moments.

— Wall Street Journal, 2020;
Business Insider, 2020

 

Download a PDF of this content below. 

 

The 2021 Health Trends Series
Realigning in Real Time
The Race to Return Safe
Download
Download

Fill out the form below to download your requested Insights Hub Article.

*Required fields

By submitting this form, you agree to our Terms & Conditions and Privacy Policy of our website. You can withdraw your consent at any time. If you have any questions, please Contact Us.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Related Content

The 2021 Health Trends Series
December 1, 2020
Realigning in Real Time
December 31, 2020
The Race to Return Safe
December 17, 2020

Chapters

Chapter:
1
Remote Care
Chapter:
2
The Race to Return Safe
Chapter:
3
Realigning in Real Time
Chapter:
4
Post-Surge Capacity
Chapter:
5
The Next Normal
Chapter:
6
Fast Launch; Long Tail

Pages

  • 1
  • 2
  • next ›
  • last »
Interested in Syneos Health?
Get In Touch
Connect
  • LinkedInLinkedIn
  • TwitterTwitter
  • FacebookFacebook
  • InstagramInstagram

Syneos Health

Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. Our Company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies – INC Research and inVentiv Health – we bring together approximately 24,000 clinical and commercial minds with the ability to support customers in more than 110 countries.

Contact Us
Our Headquarters
Corporate Headquarters
  • 1030 Sync Street
  • Morrisville, NC 27560
  •  
  • Phone: +1 919 876 9300
  • Fax: +1 919 876 9360
  • Toll-Free: +1 866 462 7373
Menu
  • Solutions
  • Therapeutic Expertise
  • Brand Directory
  • Careers
  • Study Participants
  • Media
  • Business Ethics Helpline
  • Events
  • Transparency
© 2021 Syneos Health. All Rights Reserved.
  • Terms Of Use
  • Privacy Notice
  • Privacy Shield
  • Online Tracking Opt-Out